FAF hosted its inaugural Food Allergy Fund Innovation Forum on the West Coast on October, 21, 2026. The Forum explored two of the most exciting frontiers in food allergy research: from the immune system and microbiome to the biotech innovations working toward prevention, treatments, and ultimately a cure. Investors, entrepreneurs, patients, families, clinicians, scientists, and industry leaders, all in one room.
Date: Wednesday, October 21, 2026
Time: 4:00–6:30 p.m. (Program & Networking Reception)
Location: The Commonwealth Club,
110 The Embarcadero, San Francisco, CA
REGISTRATION IS CLOSED
EVENT AGENDA
Welcome Remarks: Ilana Golant | Founder & CEO, Food Allergy Fund
Panel: The Next Generation of Food Allergy Treatments
Ashley Dombkowski| CEO & President, Cellics Therapeutics
Dr. Nikole Kimes | CEO, Siolta Therapeutics
Dr. Brian Wong | Former CEO, RAPT Therapeutics
Thomas Goetz | Creator & Host, Drug Story Podcast (moderator)
Presentations: The FAF-Funded Science Shaping the Future of Food Allergy
Dr. Susan Lynch | Director, Benioff Center for Microbiome Medicine, UCSF
Dr. Carlotta Ronda | Principal Investigator, Innovative Genomics Institute, UC Berkeley
Dr. Michael Fischbach | Director, Microbiome Therapies Initiative, Stanford University
Dr. Alexander Marson | Director, Institute of Genomic Immunology, Gladstone-UCSF
Panel: The Investment Landscape in Food Allergy
Carol Suh | ARCH Venture Partners
Dr. Gijsbert Grotenbreg | a16z Bio + Health, Andreessen Horowitz
Dr. Uri Lopatin | CEO, Ukko & Operating Partner, Khosla Ventures
Ilana Golant | Founder & CEO, Food Allergy Fund (moderator)
Confirmed speakers include:
-

Ashley Dombkowski
CEO & President, Cellics Therapeutics
-

Dr. Michael Fischbach
Director, Microbiome Therapies Initiative,
Stanford University -

Thomas Goetz
Creator & Host, Drug Story Podcast
-

Dr. Gijsbert Grotenbreg
Venture Partner,
a16z Bio + Health -

Dr. Nikole Kimes
CEO, Siolta Therapeutics
-

Dr. Uri Lopatin
CEO, Ukko
-

Dr. Susan Lynch
Director, Benioff Center for Microbiome Medicine,
UCSF -

Dr. Alexander Marson
Director, Institute of Genomic Immunology,
Gladstone-UCSF -

Dr. Carlotta Ronda
Principal Investigator,
Innovative Genomics Institute,
UC Berkeley -

Carol Suh
Partner, ARCH Venture Partners
-

Dr. Brian Wong
Former President & CEO,
RAPT Therapeutics -

Greg Yap
Partner, Menlo Ventures